As of Mar 27
| +0.07 / +0.95%|
The 7 analysts offering 12-month price forecasts for Array Biopharma Inc have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +35.14% increase from the last price of 7.40.
The current consensus among 8 polled investment analysts is to Buy stock in Array Biopharma Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.